Skip to main content
. 2019 Nov-Dec;24(6):489–496. doi: 10.5863/1551-6776-24.6.489

Table 2.

Clinical Indications, Symptoms, and Additional Prescriptions Among 6 IBD Cases and 6 Controls Prescribed PPIs, Kaiser Permanente Northern California, 1996–2016 (cont)

Case/Control (Index Age) PPI Use, Age, Duration H2 Blocker and Antibiotic Use, Age, Drug Type* Additional Prescriptions Diagnosis Gastrointestinal Symptoms Non-gastrointestinal Symptoms Primary Reason for Visit
Case (13) 8, 100 days 9, cephalosporin Azithromycin, clindamycin, fluticasone proprionate, guaifenesin, sulfamethoxazole Eosinophilic esophagitis, GERD Chronic heartburn, cough, reflux Coughing attacks, dizziness Eosinophilic esophagitis
Case (14) 10, 30 days
10, 30 days
11, 30 days
11, 50 days
11, 75 days
11, 502 days
9, sulfonamide
9, cephalosporin
10, cephalosporin
9, H2blocker
10, H2 blocker
10, H2 blocker
10, H2 blocker
10, sulfonamide
11, sulfonamide
11, sulfonamide
Sulfasalazine, erythromycin, ranitidine, valproate sodium Diarrhea, acid reflux, GERD Constipation, diarrhea, emesis Weight loss, poor growth Diarrhea, constipation, blood in stool and melena, gagging, vomiting
Case (15) 10, 30 days
10, 30 days
12, 30 days
13, cephalosporin
13, sulfonamide
Ondansetron, clindamycin phosphate Abdominal migraines, differential diagnosis: H pylori, PUD, IBS, GERD Abdominal pain None Continued abdominal pain
Case (16) 12, 10 days
12, 10 days
12, penicillin Amoxicillin, clarithromycin, desonide, azithromycin Pharyngitis Difficulty swallowing Sore throat Sore throat and difficulty swallowing, elevated H pylori
Case (17) 14, 60 days
14, 100 days
14, penicillin 15, H2 blocker Venlafaxine, neomycin polymyxin HD, amoxicillin, ondansetron, sodium chloride, hydroxyzine, citalopram, polyethylene glycol 3350 Major depression, panic disorder with agoraphobia Constipation (severe), encopresis, abdominal pain, nausea Weight loss, depression, anxiety Weight loss (15 lb over 1 year), abdominal pain, constipation, encopresis

GERD, gastroesophageal reflux disease; IBD, inflammatory bowel disease; IBS, irritable bowel syndrome; PUD, peptic ulcer disease; PPI, proton pump inhibitor

* During the 2 to 5 years before index date.

Additional prescriptions within ± 6 months of PPI prescription.